Prior studies have shown that SneakPeek® Early Gender Test can accurately this study was to evaluate the clinical performance of SneakPeek® for noninvasive prenatal testing (NIPT) to determine fetal sex at an earlier time point: 8 weeks gestation.
Introduction
Early sex determination has evolved from invasive techniques such chorionic villus sampling and amniocentesis to noninvasive prenatal testing through the analysis of cell-free fetal DNA (cffDNA 
Methods
were enlisted for this study. All participants provided informed after participants had reached at least 14 weeks gestation. Inclusion sonographic evaluation. Exclusion criteria were a refusal to give informed consent or any miscarriage within the last 3months. 
Discussion and conclusion
sensitive for male fetal cell-free DNA. This study demonstrates that SneakPeek® can accurately determine fetal sex as early as 8 weeks gestation using a microvolume amount of maternal plasma. Using a real-time quantitative polymerase chain reaction, we utilized a multiwas recovered, respectively. We accurately determined fetal sex values for the autosomal control gene were similar for plasma samples ultrasound. There was one false positive and no false negatives. The DNA from a previous male pregnancy still lingering in the maternal 11 The lack of any false negative results in this study suggests that there early as eight weeks gestation for fetal sex determination. when using non-invasive fetal diagnosis for fetal sex determination, 12, 13 knowledge of fetal gender in early pregnancy is clinically indicated if including several psychological advantages (perceived control, earlyreengagement, normalization of pregnancy and peace of mind).
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